WebDisclosure WebDisclosure
Basculer en Français
10728 Companies
229926 Keywords
158370 Articles
122076 Press releases
Headlines Articles Press releases Allessenz Remove
  1. Home
  2. Companies
  3. Allessenz
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/06/2024 at 12:50, 2 years 1 month ago

    Allessenz Unveils Revolutionary 13100mg Five-Fold Active Collagen Peptide Beverage

    Dietary Supplements Health And Wellness Collagen Peptide Beverage Anti-Aging
  • BRIEF

    published on 06/06/2024 at 12:50, 2 years 1 month ago

    Allessenz dévoile une boisson révolutionnaire à base de peptides de collagène actifs à cinq volets de 13 100 mg

    Compléments Alimentaires Santé Et Bien-être Boisson Aux Peptides De Collagène Anti-âge
  • PRESS RELEASE

    published on 06/06/2024 at 12:45, 2 years 1 month ago

    Allessenz Unveils Revolutionary 13100mg Five-Fold Active Collagen Peptide Beverage, leading a new trend in dietary health

    Allessenz launches 13100mg Five-Fold Active Collagen Peptide Beverage, promising advanced anti-aging benefits with deep hydration, wrinkle reduction, and dual-action sugar control
    Health And Wellness Nutritional Supplements Collagen Peptide Beverage Anti-Aging Allessenz
    Logo of Allessenz
Accesswire
  • Published on 07/15/2026 at 14:30, 1 hour 26 minutes ago

    Avant Brands Reports Q2 2026 Results Highlighted by 34% Growth in Recreational Revenue

  • Published on 07/15/2026 at 14:30, 1 hour 26 minutes ago

    Innodata to Report Second Quarter 2026 Results

  • Published on 07/15/2026 at 14:30, 1 hour 26 minutes ago

    Fermi Outlines Strategic Rationale for Upsized $431 Million Convertible Notes Offering

  • Published on 07/15/2026 at 14:30, 1 hour 26 minutes ago

    Sekur Private Data Launches SekurOne with Encrypted Voice for All Devices

  • Published on 07/15/2026 at 14:00, 1 hour 56 minutes ago

    GameSquare Provides Update to Capital Allocation Strategy

View all ACCESSWIRE
EQS Group
  • Published on 07/15/2026 at 15:20, 35 minutes ago

    Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

  • Published on 07/15/2026 at 15:10, 46 minutes ago

    Xryma Plc Announces Approval and Publication of its Prospectus for Admission to Trading on Euronext Paris

  • Published on 07/15/2026 at 15:05, 50 minutes ago

    Precisely Appoints New Chief Revenue Officer and Chief Business Officer as Market Demand for Agentic-Ready Data Intensifies

  • Published on 07/15/2026 at 15:05, 50 minutes ago

    Maya HTT Welcomes Friendship Systems and CAESES to Expand Simulation-Driven Design and Optimization Software Portfolio

  • Published on 07/15/2026 at 14:48, 1 hour 8 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc

View all EQS
Les Echos
  • Published on 07/15/2026 at 08:41, 7 hours 14 minutes ago

    ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 juin 2026

  • Published on 07/15/2026 at 08:00, 7 hours 56 minutes ago

    Groupe PLC, accompagné par son actionnaire majoritaire IDI, complète son offre par l’acquisition de Floralpina

  • Published on 07/13/2026 at 18:00, 1 day 21 hours ago

    CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense

  • Published on 07/13/2026 at 18:00, 1 day 21 hours ago

    PR Icade - Icade regains full ownership of the Eqho Tower in La Défense

  • Published on 07/13/2026 at 18:00, 1 day 21 hours ago

    THERMADOR GROUPE : 2026 half-year turnover

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy